NO152935C - Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. - Google Patents

Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.

Info

Publication number
NO152935C
NO152935C NO791140A NO791140A NO152935C NO 152935 C NO152935 C NO 152935C NO 791140 A NO791140 A NO 791140A NO 791140 A NO791140 A NO 791140A NO 152935 C NO152935 C NO 152935C
Authority
NO
Norway
Prior art keywords
tioetic
inflammatorally
preparation
effective
acid derivatives
Prior art date
Application number
NO791140A
Other languages
English (en)
Norwegian (no)
Other versions
NO152935B (no
NO791140L (no
Inventor
John A Edwards
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO791140L publication Critical patent/NO791140L/no
Publication of NO152935B publication Critical patent/NO152935B/no
Publication of NO152935C publication Critical patent/NO152935C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO791140A 1978-04-05 1979-04-04 Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. NO152935C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/893,388 US4188385A (en) 1978-04-05 1978-04-05 Thioetianic acid derivatives

Publications (3)

Publication Number Publication Date
NO791140L NO791140L (no) 1979-10-08
NO152935B NO152935B (no) 1985-09-09
NO152935C true NO152935C (no) 1985-12-18

Family

ID=25401484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO791140A NO152935C (no) 1978-04-05 1979-04-04 Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.

Country Status (28)

Country Link
US (1) US4188385A (xx)
EP (1) EP0004741B1 (xx)
JP (2) JPS54141758A (xx)
AR (1) AR226035A1 (xx)
AT (1) AT368168B (xx)
AU (1) AU526025B2 (xx)
CA (1) CA1134345A (xx)
CS (1) CS203956B2 (xx)
DE (2) DE2912331A1 (xx)
DK (1) DK147735C (xx)
ES (1) ES479271A1 (xx)
FI (1) FI66393C (xx)
FR (1) FR2421912A1 (xx)
GB (1) GB2018256B (xx)
GR (1) GR67275B (xx)
HK (1) HK41284A (xx)
HU (1) HU179314B (xx)
IL (1) IL56972A0 (xx)
IT (1) IT1120954B (xx)
MY (1) MY8500575A (xx)
NO (1) NO152935C (xx)
NZ (1) NZ190076A (xx)
PL (1) PL121469B1 (xx)
PT (1) PT69409A (xx)
SG (1) SG6786G (xx)
SU (1) SU1052161A3 (xx)
YU (1) YU40929B (xx)
ZA (1) ZA791635B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
US4310466A (en) * 1979-08-31 1982-01-12 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
KR850000969B1 (ko) * 1980-02-15 1985-07-02 글락소 그룹 리미티드 안드로스탄 카보티오에이트의 제조방법
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
ZA81976B (en) * 1980-02-15 1982-07-28 Glaxo Group Ltd Androstane carbothioates
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
GB9225923D0 (en) * 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
CA2149777C (en) * 1992-12-24 2004-05-25 Michael John Ashton New steroids
DE69609199T2 (de) * 1995-12-29 2001-03-01 Glaxo Group Ltd Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
AU7576001A (en) * 2000-08-05 2002-02-18 Glaxo Group Ltd 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP1383786B1 (en) * 2001-04-30 2008-10-15 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
DE60227254D1 (de) * 2001-06-12 2008-08-07 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.-heterozyklische ester von 17.beta.-carbothioat androstan derivativen
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
EP1611149A1 (en) * 2003-04-04 2006-01-04 Alpharma APS Process for the preparation of steroidal carbothioic acid derivatives and intermediates
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
AR069804A1 (es) * 2007-12-21 2010-02-17 Schering Corp Agonistas del receptor glucocorticoide c20- c21 sustituido
CN102834406A (zh) 2009-06-16 2012-12-19 默沙东公司 作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2509171A (en) * 1946-02-06 1950-05-23 Ciba Ltd Primary alcohols from thiocarboxylic acids and esters
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US3989686A (en) * 1972-06-15 1976-11-02 Glaxo Laboratories Limited Anaesthetic steroids of the androstane series and process for preparing same
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.

Also Published As

Publication number Publication date
DE2912331A1 (de) 1979-10-18
GB2018256B (en) 1983-02-02
EP0004741B1 (en) 1981-01-28
JPS611038B2 (xx) 1986-01-13
EP0004741A2 (en) 1979-10-17
HK41284A (en) 1984-05-18
GB2018256A (en) 1979-10-17
FR2421912B1 (xx) 1981-03-20
SU1052161A3 (ru) 1983-10-30
HU179314B (en) 1982-09-28
FR2421912A1 (fr) 1979-11-02
JPS6140648B2 (xx) 1986-09-10
PT69409A (en) 1979-04-01
DK136579A (da) 1979-10-06
EP0004741A3 (en) 1979-11-14
SG6786G (en) 1986-08-01
MY8500575A (en) 1985-12-31
AT368168B (de) 1982-09-27
PL214676A1 (xx) 1980-01-02
GR67275B (xx) 1981-06-26
YU40929B (en) 1986-08-31
FI66393C (fi) 1984-10-10
DK147735C (da) 1985-08-19
YU80379A (en) 1983-04-30
AU4558379A (en) 1979-10-18
DK147735B (da) 1984-11-26
FI66393B (fi) 1984-06-29
NO152935B (no) 1985-09-09
NO791140L (no) 1979-10-08
FI791081A (fi) 1979-10-06
AR226035A1 (es) 1982-05-31
US4188385A (en) 1980-02-12
CS203956B2 (en) 1981-03-31
DE2960096D1 (en) 1981-03-19
PL121469B1 (en) 1982-05-31
ATA251979A (de) 1982-01-15
JPS54141758A (en) 1979-11-05
IT7967652A0 (it) 1979-03-28
NZ190076A (en) 1984-07-31
AU526025B2 (en) 1982-12-16
ES479271A1 (es) 1980-01-16
IL56972A0 (en) 1979-05-31
IT1120954B (it) 1986-03-26
JPS6069019A (ja) 1985-04-19
CA1134345A (en) 1982-10-26
ZA791635B (en) 1980-11-26

Similar Documents

Publication Publication Date Title
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO164712C (no) Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO803470L (no) Fremgangsmaate for fremstilling av 7-acylamino-3-vinylcefalosporansyrederivater.
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
SE8001747L (sv) Forfarande for framstellning av 1-fluorerade vitamin d-foreningar
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
DK149773C (da) Analogifremgangsmaade til fremstilling af 3-quinolincarboxylsyrederivater
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
FI793367A (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-yl-urinaemnen
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
FI793307A (fi) Foerfarande foer framstaellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO147310C (no) Fremgangsmaate for fremstilling av substituerte antitumorantracykliner
NO155009C (no) Fremgangsmaate for fremstilling av natriumamoxicillin.
NO790328L (no) Fremgangsmaate ved fremstilling av derivater av nafthyl-1-eddiksyre.